These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 24106933)

  • 1. No easy fixes.
    Taqueti VR
    N Engl J Med; 2013 Oct; 369(15):1392-3. PubMed ID: 24106933
    [No Abstract]   [Full Text] [Related]  

  • 2. Should We Up the Intensity of Statin Therapy After Placing a Drug-eluting Stent?
    Parikh KH; Kirtane AJ
    Rev Esp Cardiol (Engl Ed); 2018 Jun; 71(6):416-417. PubMed ID: 29104001
    [No Abstract]   [Full Text] [Related]  

  • 3. Coated stents: a novel approach to prevent in-stent restenosis.
    Curcio A; Torella D; Coppola C; Mongiardo A; Cireddu M; Falco M; Chiariello M; Indolfi C
    Ital Heart J; 2002 Jun; 3 Suppl 4():16S-19S. PubMed ID: 12116820
    [No Abstract]   [Full Text] [Related]  

  • 4. A new look at HDL in coronary disease: can we escape natural history?
    Gielen S; Landmesser U
    Heart; 2011 Dec; 97(23):1899-901. PubMed ID: 21835756
    [No Abstract]   [Full Text] [Related]  

  • 5. Coronary Computed Tomography Angiography in the Evaluation of Chest Pain of Suspected Cardiac Origin.
    Bittencourt MS; Hulten EA; Veeranna V; Blankstein R
    Circulation; 2016 May; 133(20):1963-8. PubMed ID: 27185023
    [No Abstract]   [Full Text] [Related]  

  • 6. Why do diabetic patients with multiple risk factors develop plaque progression rapidly despite interventional procedure and statin treatment.
    Seo JG; Han SH; Kim SH; Ahn TH; Koh KK
    Int J Cardiol; 2013 Oct; 168(3):2962-4. PubMed ID: 23602869
    [No Abstract]   [Full Text] [Related]  

  • 7. Statins and prevention of stent-related late adverse events.
    Uemura S
    Coron Artery Dis; 2014 Jun; 25(4):277-8. PubMed ID: 24710353
    [No Abstract]   [Full Text] [Related]  

  • 8. Restenosis after successful ostial stent implantation: the role of statins compared with conventional treatment.
    Horlitz M; Amin FR; Boerrigter G; Sigwart U; Clague JR
    J Interv Cardiol; 2004 Oct; 17(5):301-6. PubMed ID: 15491333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-stent late total occlusion following left main coronary artery stenting.
    Canbay A; Ozcan O
    Acta Cardiol; 2008 Oct; 63(5):639-40. PubMed ID: 19014010
    [No Abstract]   [Full Text] [Related]  

  • 10. Severe right coronary artery kinking treated with stent placement.
    Seol SH; Song PS; Kim DK; Kim DI
    Intern Med; 2013; 52(10):1143-4. PubMed ID: 23676607
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison between catheter-based delivery of paclitaxel after bare-metal stenting and drug-eluting stents in coronary artery disease patients at high risk for in-stent restenosis.
    El-Mokadem M; El-Ramly M; Hassan A; Boshra H; AbdelWahab A
    Cardiovasc Revasc Med; 2017 Dec; 18(8):596-600. PubMed ID: 28625402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of statin non-adherence on in-stent restenosis following bare-metal stent implantation.
    Kocas C; Abaci O; Kocas BB; Cetinkal G; Arslan S; Yildiz A; Ersanli M
    Int J Cardiol; 2016 Jan; 203():529-31. PubMed ID: 26569357
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug-eluting stent in saphenous vein graft lesions.
    Kornowski R
    Catheter Cardiovasc Interv; 2008 Jun; 71(7):894-5. PubMed ID: 18498140
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug-eluting stents for drug-eluting stent restenosis: stick with the old or switch to a new one?
    Kufner S; Kastrati A
    Coron Artery Dis; 2014 Dec; 25(8):633-5. PubMed ID: 25365642
    [No Abstract]   [Full Text] [Related]  

  • 15. Do statins have a role in reduction/prevention of post-PCI restenosis?
    Prasad K
    Cardiovasc Ther; 2013 Feb; 31(1):12-26. PubMed ID: 21967674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomised determination of the Effect of Fluvastatin and Atorvastatin on top of dual antiplatelet treatment on platelet aggregation after implantation of coronary drug-eluting stents. The EFA-Trial.
    Wenaweser P; Eshtehardi P; Abrecht L; Zwahlen M; Schmidlin K; Windecker S; Meier B; Haeberli A; Hess OM
    Thromb Haemost; 2010 Sep; 104(3):554-62. PubMed ID: 20664903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of mTOR pathway inhibition in the neointimal hyperplasia and promoting macrophage autophagy - Effect of statin-eluting stents to reduce in-stent restenosis.
    Hu HJ; Zhou SH; Liu QM
    Int J Cardiol; 2015; 187():31-2. PubMed ID: 25828306
    [No Abstract]   [Full Text] [Related]  

  • 18. 3-Year Clinical Follow-Up of the RIBS IV Clinical Trial: A Prospective Randomized Study of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis in Coronary Arteries Previously Treated With Drug-Eluting Stents.
    Alfonso F; Pérez-Vizcayno MJ; Cuesta J; García Del Blanco B; García-Touchard A; López-Mínguez JR; Masotti M; Zueco J; Cequier A; Velázquez M; Moreno R; Mainar V; Domínguez A; Moris C; Molina E; Rivero F; Jiménez-Quevedo P; Gonzalo N; Fernández-Pérez C;
    JACC Cardiovasc Interv; 2018 May; 11(10):981-991. PubMed ID: 29798776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of restenosis in drug-eluting stents: still a challenge!
    Gupta M; Kadakia J; Budoff MJ
    J Invasive Cardiol; 2010 May; 22(5):220-1. PubMed ID: 20440038
    [No Abstract]   [Full Text] [Related]  

  • 20. Fracture of zotarolimus-eluting stent after implantation.
    Wu MC; Cheng CC; Huang TY
    Tex Heart Inst J; 2009; 36(6):618-20. PubMed ID: 20069095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.